Lowered Expectations – The Story Behind The HRT News
By Madeline Behrendt, D.C. This week women’s health headlined print and media stories around the globe. What triggered this attention was the halting of an 8-year U.S. Federal study that evaluated the risks/benefits of combination Hormone Replacement Therapy (HRT), treatment which includes estrogen and progestin (i.e. Prempro). NIH, which ran the study, notified the public,